Kaderbhai M A, Bradshaw T K, Freedman R B
Chem Biol Interact. 1981 Aug;36(2):211-27. doi: 10.1016/0009-2797(81)90021-1.
Incubation of 2-[9-14C]acetylaminofluorene (2-[9-14C]AAF) in vitro with rat liver microsomes, leads to covalent binding of label to microsomal proteins. The binding is NADPH-dependent, increases linearly with time, and is inhibited by SKF-525A and 7,8-benzoflavone (7,8-BF). Binding is increased more than 8-fold in microsomes from 3-methylcholanthrene(MC)-pretreated rats, but only less than 2-fold in those from phenobarbital(PB)-pretreated rats. In the presence of cytosolic proteins, there is slight enhancement of the labelling of microsomes and some labelling of the cytosolic proteins. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and 2-dimensional gel electrophoresis indicate that covalent labelling by 2-AAF derivatives is concentrated in specific proteins. The pattern of labelling varies between microsomes from animals pretreated with PB, MC and 2-AAF. Factors which may contribute to the specificity of labelling are discussed.
将2-[9-¹⁴C]乙酰氨基芴(2-[9-¹⁴C]AAF)与大鼠肝脏微粒体进行体外孵育,会导致标记物与微粒体蛋白发生共价结合。这种结合依赖于NADPH,随时间呈线性增加,并受到SKF-525A和7,8-苯并黄酮(7,8-BF)的抑制。来自经3-甲基胆蒽(MC)预处理大鼠的微粒体中的结合增加了8倍以上,但来自经苯巴比妥(PB)预处理大鼠的微粒体中仅增加了不到2倍。在存在胞质蛋白的情况下,微粒体的标记略有增强,并且胞质蛋白也有一些标记。十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)和二维凝胶电泳表明,2-AAF衍生物的共价标记集中在特定蛋白质中。标记模式在经PB、MC和2-AAF预处理动物的微粒体之间有所不同。讨论了可能导致标记特异性的因素。